Nomura Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-94,829
Closed -$1.59M 1803
2017
Q4
$1.59M Sell
94,829
-18,954
-17% -$347K ﹤0.01% 962
2017
Q3
$2.32M Buy
113,783
+15,735
+16% +$301K ﹤0.01% 801
2017
Q2
$1.58M Buy
98,048
+16,032
+20% +$237K ﹤0.01% 905
2017
Q1
$1.04M Buy
82,016
+8,413
+11% +$102K ﹤0.01% 776
2016
Q4
$970K Sell
73,603
-54,545
-43% -$932K ﹤0.01% 1068
2016
Q3
$3.06M Sell
128,148
-13,549
-10% -$364K 0.01% 578
2016
Q2
$4.17M Buy
+141,697
New +$4.62M 0.01% 472
2016
Q1
Sell
-160,024
Closed -$6.86M 2226
2015
Q4
$6.86M Buy
160,024
+10,155
+7% +$406K 0.02% 330
2015
Q3
$5.29M Buy
149,869
+141,269
+1,643% +$6.36M 0.02% 376
2015
Q2
$395K Buy
+8,600
New +$408K ﹤0.01% 1346
2014
Q3
Sell
-90,756
Closed -$2.71M 3205
2014
Q2
$2.71M Buy
90,756
+77,128
+566% +$2.08M ﹤0.01% 986
2014
Q1
$361K Buy
+13,628
New +$341K ﹤0.01% 1969

Other funds holding IPXL

Nomura Holdings's IPXL Position: Q1 2018 in Review

Nomura Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 94,829 shares — an estimated $1.59M sold.

Nomura Holdings first reported a position in IPXL in Q1 2014 and held it in 12 quarters. The position peaked at $6.86M in Q4 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • Nomura Holdings reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • Nomura Holdings sold 94,829 Impax Laboratories, Inc. shares in Q1 2018, an estimated $1.59M.
  • Nomura Holdings first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 12 quarters.
  • Nomura Holdings's Impax Laboratories, Inc. position peaked at $6.86M in Q4 2015.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Nomura Holdings's 13F filing for Q1 2018, filed 14 May 2018.